Distinct Pattern of Matrix Metalloproteinase 9 and Tissue Inhibitor of Metalloproteinase 1 MRNA Expression in Human Colorectal Cancer and Liver Metastases

Overview

Journal Br J Cancer

Specialty Oncology

Date 1995 Sep 1

PMID 7669564

Citations 26

Authors

Z S Zeng

J G Guillem

Affiliations

Soon will be listed here.

Abstract

The matrix metalloproteinases (MMPs) and tissue inhibitors of metalloproteinases (TIMPs) are perceived as essential for tumour invasion and metastasis. In the present study, we compare the topographical pattern of MMP-9 and TIMP-1 expression in colorectal cancer and liver metastasis by in situ hybridisation. TIMP-1 mRNA was detected in all 26 colorectal cancers examined, while only 18 out of 26 (69.2%) were positive for MMP-9. Both MMP-9 and TIMP-1 mRNA were observed in all ten liver metastases but were absent in three adenomas and in all normal colonic mucosa and liver. There was no association between MMP-9 or TIMP-1 mRNA expression and degree of differentiation or size of Tumours. MMP-9 and TIMP-1 mRNA were similarly observed in the peritumour stroma cells rather than in tumour cells themselves. MMP-9 mRNA positive cells were round and identified as macrophages by immunostaining with an anti-macrophage antibody (KP1), while TIMP-1, mRNA was detected in spindle-shaped stromal cells. In liver metastases, MMP-9 localised within peritumour stroma or at the interface between the tumour stroma and normal liver, whereas TIMP-1 mRNA was located throughout the malignant tumour stroma. Our data demonstrate a distinct pattern of MMP-9 and TIMP-1 mRNA expression in colorectal cancer and liver metastases suggesting distinct cellular origins as well as separate patterns of regulation.

Citing Articles

The Simultaneous Effects of miR-145-5p and hsa-let-7a-3p on Colorectal Tumorigenesis: In Vitro Evidence.

Mozammel N, Baghbani E, Amini M, Zaer S, Baghay Esfandyari Y, Tohidast M Adv Pharm Bull. 2024; 14(1):231-240.

PMID: 38585468 PMC: 10997926. DOI: 10.34172/apb.2024.004.

Profile of Expression of Genes Encoding Matrix Metallopeptidase 9 (MMP9), Matrix Metallopeptidase 28 (MMP28) and TIMP Metallopeptidase Inhibitor 1 (TIMP1) in Colorectal Cancer: Assessment of the Role in Diagnosis and Prognostication.

Lorenc Z, Waniczek D, Lorenc-Podgorska K, Krawczyk W, Domagala M, Majewski M Med Sci Monit. 2017; 23:1305-1311.

PMID: 28293015 PMC: 5363457. DOI: 10.12659/msm.901593.

MMP7 is required to mediate cell invasion and tumor formation upon Plakophilin3 loss.

Basu S, Thorat R, Dalal S PLoS One. 2015; 10(4):e0123979.

PMID: 25875355 PMC: 4395386. DOI: 10.1371/journal.pone.0123979.

Tissue inhibitor of matrix metalloproteinase-1 expression in colorectal cancer liver metastases is associated with vascular structures.

Illemann M, Lovendahl Eefsen R, Bird N, Majeed A, Osterlind K, Laerum O Mol Carcinog. 2015; 55(2):193-208.

PMID: 25594187 PMC: 6680289. DOI: 10.1002/mc.22269.

Influence of Stromal Components on Lung Cancer Carcinogenesis.

Shuman Moss L, Stetler-Stevenson W J Carcinog Mutagen. 2013; 13(8).

PMID: 24205446 PMC: 3818080. DOI: 10.4172/2157-2518.S13-008.

References

Dean D, Schwartz Z, Muniz O, Gomez R, Swain L, Howell D . Matrix vesicles contain metalloproteinases that degrade proteoglycans. Bone Miner. 1992; 17(2):172-6. DOI: 10.1016/0169-6009(92)90731-r. View

Hayakawa T, Yamashita K, Tanzawa K, Uchijima E, Iwata K . Growth-promoting activity of tissue inhibitor of metalloproteinases-1 (TIMP-1) for a wide range of cells. A possible new growth factor in serum. FEBS Lett. 1992; 298(1):29-32. DOI: 10.1016/0014-5793(92)80015-9. View

Pavloff N, Staskus P, Kishnani N, Hawkes S . A new inhibitor of metalloproteinases from chicken: ChIMP-3. A third member of the TIMP family. J Biol Chem. 1992; 267(24):17321-6. View

Urbanski S, Edwards D, Maitland A, Leco K, Watson A, Kossakowska A . Expression of metalloproteinases and their inhibitors in primary pulmonary carcinomas. Br J Cancer. 1992; 66(6):1188-94. PMC: 1978055. DOI: 10.1038/bjc.1992.434. View

Boag A, Young I . Immunohistochemical analysis of type IV collagenase expression in prostatic hyperplasia and adenocarcinoma. Mod Pathol. 1993; 6(1):65-8. View

Pyke C, Ralfkiaer E, Tryggvason K, Dano K . Messenger RNA for two type IV collagenases is located in stromal cells in human colon cancer. Am J Pathol. 1993; 142(2):359-65. PMC: 1886712. View

Chang E, Welgus H, Parks W . Expression of interstitial collagenase, 92-kDa gelatinase, and tissue inhibitor of metalloproteinases-1 in granuloma annulare and necrobiosis lipoidica diabeticorum. J Invest Dermatol. 1993; 100(3):335-42. DOI: 10.1111/1523-1747.ep12470032. View

Brown P, Bloxidge R, Stuart N, Gatter K, Carmichael J . Association between expression of activated 72-kilodalton gelatinase and tumor spread in non-small-cell lung carcinoma. J Natl Cancer Inst. 1993; 85(7):574-8. DOI: 10.1093/jnci/85.7.574. View

Davies B, Miles D, Happerfield L, Naylor M, Bobrow L, Rubens R . Activity of type IV collagenases in benign and malignant breast disease. Br J Cancer. 1993; 67(5):1126-31. PMC: 1968428. DOI: 10.1038/bjc.1993.207. View

10.

Davies B, Waxman J, Wasan H, Abel P, Williams G, Krausz T . Levels of matrix metalloproteases in bladder cancer correlate with tumor grade and invasion. Cancer Res. 1993; 53(22):5365-9. View

11.

Newell K, Witty J, Rodgers W, Matrisian L . Expression and localization of matrix-degrading metalloproteinases during colorectal tumorigenesis. Mol Carcinog. 1994; 10(4):199-206. DOI: 10.1002/mc.2940100404. View

12.

Clark I, Powell L, Cawston T . Tissue inhibitor of metalloproteinases (TIMP-1) stimulates the secretion of collagenase from human skin fibroblasts. Biochem Biophys Res Commun. 1994; 203(2):874-80. DOI: 10.1006/bbrc.1994.2264. View

13.

Zeng Z, Sarkis A, Zhang Z, Klimstra D, Charytonowicz E, Guillem J . p53 nuclear overexpression: an independent predictor of survival in lymph node--positive colorectal cancer patients. J Clin Oncol. 1994; 12(10):2043-50. DOI: 10.1200/JCO.1994.12.10.2043. View

14.

Zeng Z, Hsu S, Zhang Z, Cohen A, Enker W, Turnbull A . High level of Nm23-H1 gene expression is associated with local colorectal cancer progression not with metastases. Br J Cancer. 1994; 70(5):1025-30. PMC: 2033541. DOI: 10.1038/bjc.1994.442. View

15.

Ennis B, Matrisian L . Matrix degrading metalloproteinases. J Neurooncol. 1993; 18(2):105-9. DOI: 10.1007/BF01050416. View

16.

Woessner Jr J . The family of matrix metalloproteinases. Ann N Y Acad Sci. 1994; 732:11-21. DOI: 10.1111/j.1749-6632.1994.tb24720.x. View

17.

Liotta L, Tryggvason K, Garbisa S, Hart I, FOLTZ C, Shafie S . Metastatic potential correlates with enzymatic degradation of basement membrane collagen. Nature. 1980; 284(5751):67-8. DOI: 10.1038/284067a0. View

18.

Murphy G, Cawston T, Reynolds J . An inhibitor of collagenase from human amniotic fluid. Purification, characterization and action on metalloproteinases. Biochem J. 1981; 195(1):167-70. PMC: 1162867. DOI: 10.1042/bj1950167. View

19.

Stricklin G, Welgus H . Human skin fibroblast collagenase inhibitor. Purification and biochemical characterization. J Biol Chem. 1983; 258(20):12252-8. View

20.

Hibbs M, Hasty K, Seyer J, Kang A, Mainardi C . Biochemical and immunological characterization of the secreted forms of human neutrophil gelatinase. J Biol Chem. 1985; 260(4):2493-500. View